OncoveryCare Company Profile

Background

Overview

OncoveryCare is a pioneering virtual cancer survivorship clinic dedicated to providing comprehensive, whole-person care for individuals living with and beyond cancer. Founded by a breast cancer survivor, the company aims to address the unique challenges faced by cancer survivors by offering personalized, longitudinal care that empowers them to lead healthier, happier lives.

Mission and Vision

OncoveryCare's mission is to revolutionize cancer survivorship care by delivering integrated support that encompasses both physical and mental health needs. The vision is a world where surviving cancer is not just about enduring but thriving, ensuring that survivors receive the necessary tools and support to navigate life after cancer.

Industry Significance

As the population of cancer survivors grows rapidly due to advancements in medical treatments, the need for specialized survivorship care becomes increasingly critical. OncoveryCare's innovative approach fills a significant gap in the healthcare continuum, offering a structured and comprehensive model that addresses the multifaceted challenges faced by survivors.

Key Strategic Focus

Core Objectives

OncoveryCare focuses on delivering personalized, whole-person care to cancer survivors, emphasizing the management of both short-term and long-term effects of cancer treatment. The company aims to provide survivors with the necessary tools and support to actively manage their survivorship journey, leading to improved health outcomes and quality of life.

Areas of Specialization

The company's key areas of specialization include:

Toxicity Management: Addressing and mitigating the adverse effects of cancer treatments.

Mental Health Support: Providing resources and care for anxiety, depression, and other mental health challenges associated with cancer survivorship.

Navigation and Care Planning: Assisting survivors in understanding and managing their ongoing care needs.

Preventative Care: Implementing strategies to prevent recurrence and promote overall health.

Key Technologies Utilized

OncoveryCare leverages telemedicine platforms to deliver virtual care, ensuring accessibility and convenience for survivors. The company employs data analytics to monitor patient progress and outcomes, enabling personalized care plans. Additionally, OncoveryCare utilizes evidence-based guidelines to inform treatment and support strategies.

Primary Markets Targeted

Initially focusing on the Tennessee region through a partnership with Tennessee Oncology, OncoveryCare aims to expand its services nationwide, addressing the needs of cancer survivors across the United States.

Financials and Funding

Funding History

OncoveryCare secured a $4.5 million seed funding round in May 2024. The round was led by .406 Ventures, with participation from the McKay Institute for Oncology Transformation at Tennessee Oncology, Oncology Ventures, and Techstars.

Utilization of Capital

The funds are intended to support the expansion of OncoveryCare's care delivery model and the development of novel tools and approaches to scale access to high-quality survivorship care more broadly.

Pipeline Development

As a virtual care provider, OncoveryCare's pipeline focuses on the continuous enhancement of its survivorship care model. The company is developing integrated programs that address the comprehensive needs of cancer survivors, including physical health services, mental health support, survivorship care planning, and navigation to community resources and referrals.

Technological Platform and Innovation

Proprietary Technologies

OncoveryCare utilizes a proprietary telemedicine platform that facilitates virtual consultations, enabling survivors to access care from the comfort of their homes. The platform integrates with electronic health records to provide a seamless experience for both patients and clinicians.

Significant Scientific Methods

The company employs evidence-based guidelines to inform care plans, ensuring that interventions are grounded in the latest research. Additionally, OncoveryCare utilizes data analytics to monitor patient outcomes and adjust care strategies accordingly.

Leadership Team

Hil Moss, MBA/MPH – Co-Founder & CEO

A breast cancer survivor, Hil is an active patient advocate, mentor, and writer in the cancer community. She holds a BA from Princeton University and an MBA/MPH from Yale University. Prior to founding OncoveryCare, Hil worked with various healthcare companies, including Hologic, LUCA Biologics, Thrive Earlier Detection, OncoHealth, and Amwell.

Dr. Justin Grischkan, MD – Co-Founder & Chief Medical Officer

A primary care physician, Dr. Grischkan holds an MD from the University of Rochester School of Medicine and completed his training in internal medicine at Massachusetts General Hospital. He has developed expertise in health policy and healthcare innovation, focusing on home-based and technology-enabled care models for patients with cancer.

Catherine M. Alfano, PhD – Chief Product & Strategy Officer

An international leader in cancer survivorship and rehabilitation, Dr. Alfano has driven advances in care delivery and improved clinical outcomes through her research and leadership roles. She has authored over 180 peer-reviewed articles and led numerous studies focusing on the chronic and late effects of cancer.

Dr. Erin Macrae, MD – Medical Director

A community oncologist based in Columbus, Ohio, Dr. Macrae completed her fellowship training in hematology and oncology at Dana-Farber Cancer Institute/Massachusetts General Hospital. She has held numerous leadership positions and contributed to clinical cancer research.

Natasha Steele, MD/MPH – Peer & Navigation Program Lead

A cancer survivor and physician with a background in public health, Dr. Steele leads innovation to leverage the impact of peer support, care navigation, and community engagement. She is currently on the faculty of Stanford University School of Medicine.

Leadership Changes

As of December 28, 2025, there have been no publicly announced significant changes or appointments within OncoveryCare's leadership team.

Competitor Profile

Market Insights and Dynamics

The market for cancer survivorship care is expanding rapidly, with the number of cancer survivors in the United States expected to reach 26 million by 2040. This growth is driven by advancements in cancer treatments and early detection, leading to improved survival rates. Consequently, there is an increasing demand for specialized care models that address the unique needs of survivors.

Competitor Analysis

Key competitors in the cancer survivorship care space include:

Tennessee Oncology: One of the nation's largest community-based cancer care practices, treating half of Tennessee's cancer patients across 35 clinical sites.

New York Cancer & Blood Specialists (NYCBS): A leading oncology practice dedicated to providing world-class, patient-centered, and affordable care to individuals with cancer and blood disorders throughout New York State.

These organizations offer comprehensive cancer care services but may not provide the same level of specialized survivorship care as OncoveryCare.

Strategic Collaborations and Partnerships

OncoveryCare has established significant partnerships to enhance its service offerings:

Tennessee Oncology: In May 2024, OncoveryCare partnered with Tennessee Oncology, enabling the company to offer its care model to patients across Tennessee.

New York Cancer & Blood Specialists (NYCBS): In September 2025, OncoveryCare collaborated with NYCBS to provide personalized, ongoing care to the NYCBS survivor population, integrating survivorship-trained clinicians into the existing oncology team.

Operational Insights

OncoveryCare's virtual care model offers several strategic advantages:

Accessibility: By providing virtual consultations, OncoveryCare ensures that survivors, regardless of their location, can access specialized care.

Integration: The company's model integrates seamlessly with existing oncology practices, enhancing the overall care continuum without disrupting established workflows.

Scalability: The virtual nature of OncoveryCare's services allows for rapid scaling, enabling the company to expand its reach to a broader population of survivors.